{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:12:08Z","timestamp":1772021528677,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12621-2","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:33:04Z","timestamp":1769851984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genital tract infections, antiretroviral treatment and HIV-1 viral load in early postpartum women: : implications for sexual and breastfeeding HIV transmission"],"prefix":"10.1186","volume":"26","author":[{"given":"Vani","family":"Govender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerusha","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhayendre","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"12621_CR1","unstructured":"UNAIDS. AIDS targets: putting the world on track to end AIDS as a public health threat by 2030. 2025; 2020. Geneva. Joint United Nations Programme on HIV\/AIDS. Available from: https:\/\/www.unaids.org."},{"issue":"12","key":"12621_CR2","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1086\/648446","volume":"49","author":"R Becquet","year":"2009","unstructured":"Becquet R, Ekouevi DK, Arrive E, Stringer JS, Meda N, Chaix ML, et al. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis. 2009;49(12):1936\u201345. https:\/\/doi.org\/10.1086\/648446.","journal-title":"Clin Infect Dis"},{"key":"12621_CR3","doi-asserted-by":"publisher","unstructured":"Davis NL, Miller WC, Hudgens MG, Chasela CS, Sichali D, Kayira D, et al. BAN study Team. Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission. AIDS. 2014;28(18):2739\u201349. https:\/\/doi.org\/10.1097\/QAD.0000000000000492.","DOI":"10.1097\/QAD.0000000000000492"},{"key":"12621_CR4","doi-asserted-by":"publisher","first-page":"906271","DOI":"10.3389\/fviro.2022.906271","volume":"2","author":"K Duri","year":"2022","unstructured":"Duri K, Mataramvura H, Chandiwana P, Mazhandu AJ, Banhwa S, Munjoma PT, et al. Mother-to-child transmission of HIV within 24 months after delivery in women initiating lifelong antiretroviral therapy pre\/post-conception or postnatally: effects of adolescent girl and young woman status and plasma viremia late in pregnancy. Front Virol. 2022;2:906271. https:\/\/doi.org\/10.3389\/fviro.2022.906271.","journal-title":"Front Virol"},{"issue":"4","key":"12621_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/QAI.0000000000001612","volume":"77","author":"PM Flynn","year":"2018","unstructured":"Flynn PM, Taha TE, Cababasay M, Fowler MG, Mofenson LM, Owor M, et al. PROMISE study Team. Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open-label, clinical trial. J Acquir Immune Defic Syndr. 2018;77(4):383\u201392. https:\/\/doi.org\/10.1097\/QAI.0000000000001612.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"12621_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1086\/315714","volume":"182","author":"K Sturm-Ramirez","year":"2000","unstructured":"Sturm-Ramirez K, Gaye-Diallo A, Eisen G, Mboup S, Kanki PJ. High levels of tumor necrosis factor-\u03b1 and interleukin-1\u03b2 in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis. 2000;182(2):467\u201373. https:\/\/doi.org\/10.1086\/315714.","journal-title":"J Infect Dis"},{"issue":"4","key":"12621_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00002030-200003100-00011","volume":"14","author":"S Cu-Uvin","year":"2000","unstructured":"Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS. 2000;14(4):415\u201321. https:\/\/doi.org\/10.1097\/00002030-200003100-00011.","journal-title":"AIDS"},{"issue":"9","key":"12621_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa1506816.","journal-title":"N Engl J Med"},{"issue":"9","key":"12621_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1600693.","journal-title":"N Engl J Med"},{"key":"12621_CR10","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1097\/00002030-200310170-00004","volume":"17","author":"JR Fiore","year":"2003","unstructured":"Fiore JR, Suligoi B, Saracino A, Di SM, Bugarini R, Lepera A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 2003;17:2169\u201376.","journal-title":"AIDS"},{"issue":"16","key":"12621_CR11","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1097\/QAD.0b013e32833e5043","volume":"24","author":"S Cu-Uvin","year":"2010","unstructured":"Cu-Uvin S, DeLong AK, Venkatesh KK, Hogan JW, Ingersoll J, Kurpewski J, et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS. 2010;24(16):2489\u201397.","journal-title":"AIDS"},{"issue":"3","key":"12621_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1067\/mob.2001.108999","volume":"184","author":"TC Wright Jr","year":"2001","unstructured":"Wright TC Jr, Subbarao S, Ellerbrock TV, Lennox JL, Evans-Strickfaden T, Smith DG, et al. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol. 2001;184(3):279\u201385.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"12621_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1086\/426394","volume":"191","author":"BE Sha","year":"2005","unstructured":"Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005;191(1):25\u201332.","journal-title":"J Infect Dis"},{"issue":"3","key":"12621_CR14","doi-asserted-by":"publisher","first-page":"e17480","DOI":"10.1371\/journal.pone.0017480","volume":"6","author":"C Tanton","year":"2011","unstructured":"Tanton C, Weiss HA, Le GJ, Changalucha J, Rusizoka M, Baisley K, et al. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One. 2011;6(3):e17480. https:\/\/doi.org\/10.1371\/journal.pone.0017480.","journal-title":"PLoS One"},{"issue":"3","key":"12621_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.ajog.2004.10.609","volume":"192","author":"A Spinillo","year":"2005","unstructured":"Spinillo A, Zara F, Gardella B, Preti E, Mainini R, Maserati R. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. Am J Obstet Gynecol. 2005;192(3):774\u201379.","journal-title":"Am J Obstet Gynecol"},{"issue":"14","key":"12621_CR16","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1097\/00002030-200009290-00005","volume":"14","author":"PS Reichelderfer","year":"2000","unstructured":"Reichelderfer PS, Coombs RW, Wright DJ, Cohn J, Burns D, Cu-Uvin S, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. AIDS. 2000;14(14):2101\u201307.","journal-title":"AIDS"},{"issue":"1","key":"12621_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","volume":"12","author":"R Heffron","year":"2012","unstructured":"Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Partners in prevention HSV\/HIV transmission study Team. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis. 2012;12(1):19\u201326.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"12621_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/QAD.0b013e32835ad539","volume":"27","author":"CB Polis","year":"2013","unstructured":"Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27(4):493\u2013505.","journal-title":"AIDS"},{"key":"12621_CR19","unstructured":"UNAIDS. UNAIDS fact sheet 2023 [Internet]. 2023 [cited 2025 Mar 25]. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf."},{"key":"12621_CR20","unstructured":"National Department of Health. Sexually transmitted infections: management guidelines 2018. 2018. Pretoria: National Department of Health. Available at https:\/\/www.health.gov.za\/wp-content\/uploads\/2020\/11\/sti-guidelines-27-08-19.pdf. Accessed 26 Mar. 2025."},{"issue":"5","key":"12621_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/sti.2008.030353","volume":"84","author":"LF Johnson","year":"2008","unstructured":"Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Infect. 2008;84(5):355\u201360. https:\/\/doi.org\/10.1136\/sti.2008.030353.","journal-title":"Sex Transm Infect"},{"issue":"11","key":"12621_CR22","doi-asserted-by":"publisher","first-page":"e009036","DOI":"10.1136\/bmjopen-2015-009036","volume":"5","author":"ML Alcaide","year":"2015","unstructured":"Alcaide ML, Chisembele M, Malupande E, Arheart K, Fischl M, Jones DL. A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women\u2019s health. BMJ Open. 2015 Nov 9;5(11):e009036. https:\/\/doi.org\/10.1136\/bmjopen-2015-009036. PMID: 26553833; PMCID: PMC4654361.","journal-title":"BMJ Open"},{"issue":"4","key":"12621_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/jwh.2012.3849","volume":"22","author":"KK Venkatesh","year":"2013","unstructured":"Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, et al. Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load. J Womens Health (Larchmt). 2013 Apr;22(4):330\u201338.","journal-title":"J Womens Health (Larchmt)"},{"issue":"16","key":"12621_CR24","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1097\/QAD.0b013e32833e5043","volume":"24","author":"S Cu-Uvin","year":"2010","unstructured":"Cu-Uvin S, DeLong AK, Venkatesh KK, Hogan JW, Ingersoll J, Kurpewski J, et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS. 2010 Oct 23;24(16):2489\u201397.","journal-title":"AIDS"},{"issue":"5","key":"12621_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.7196\/SAMJ.2021.v111i5.15240","volume":"111","author":"F Moyo","year":"2021","unstructured":"Moyo F, Mazanderani AH, Kufa T, Sherman GG. Maternal HIV viral load testing during pregnancy and postpartum care in Gauteng Province, South Africa. S Afr Med J. 2021 Apr 30;111(5):469\u201373.","journal-title":"S Afr Med J"},{"issue":"2","key":"12621_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/QAD.0000000000002733","volume":"35","author":"F Moyo","year":"2021","unstructured":"Moyo F, Mazanderani AH, Murray T, Sherman GG, Kufa T. Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa. AIDS. 2021, Feb, 2;35(2):307\u201316.","journal-title":"AIDS"},{"issue":"6","key":"12621_CR27","doi-asserted-by":"publisher","first-page":"e25290","DOI":"10.1002\/jia2.25290","volume":"22","author":"M Landes","year":"2019","unstructured":"Landes M, van Lettow M, Nkhoma E, Tippett Barr B, Truwah Z, Shouten E, et al. Low detectable postpartum viral load is associated with HIV transmission in Malawi\u2019s prevention of mother-to-child transmission programme. J Int AIDS Soc. 2019 Jun;22(6):e25290.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"12621_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/infdis\/jiaa169","volume":"222","author":"ME Bull","year":"2020","unstructured":"Bull ME, Mitchell C, Soria J, et al. Genital shedding of human immunodeficiency virus type-1 (HIV) when antiretroviral therapy (ART) suppresses HIV replication in the plasma. J Infect Dis. 2020;222(5):777\u201386. https:\/\/doi.org\/10.1093\/infdis\/jiaa169.","journal-title":"J Infect Dis"},{"issue":"13","key":"12621_CR29","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/QAD.0b013e3281532c82","volume":"21","author":"CD Pilcher","year":"2007","unstructured":"Pilcher CD, Joaki G, Hoffman IF, Martinson FE, Mapanje C, Stewart PW, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS. 2007;21(13):1723\u201330.","journal-title":"AIDS"},{"issue":"2","key":"12621_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s100960000442","volume":"20","author":"M Debiaggi","year":"2001","unstructured":"Debiaggi M, Zara F, Spinillo A, Maserati R, Bruno R, et al. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2001;20(2):91\u201396.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"12621_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF03405471","volume":"99","author":"P O\u2019Byrne","year":"2008","unstructured":"O\u2019Byrne P, MacPherson PA. Understanding HIV viral load: implications for counselling. Can J Public Health. 2008;99(3):189\u201391.","journal-title":"Can J Public Health"},{"issue":"9","key":"12621_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1468-1293.2009.00725.x","volume":"10","author":"G Lorello","year":"2009","unstructured":"Lorello G, Pilon R, Zhang G, Karnauchow T, MacPherson P. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med. 2009;10(9):548\u201354.","journal-title":"HIV Med"},{"issue":"10","key":"12621_CR33","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1086\/656790","volume":"202","author":"SM Graham","year":"2010","unstructured":"Graham SM, Masese L, Gitau R, Jalalian-Lechak Z, Richardson BA, Peshu N, et al. Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment. J Infect Dis. 2010;202(10):1538\u201342.","journal-title":"J Infect Dis"},{"issue":"8","key":"12621_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/QAD.0b013e328352ae09","volume":"26","author":"S Lambert-Niclot","year":"2012","unstructured":"Lambert-Niclot S, Tubiana R, Beaudoux C, Lefebvre G, Caby F, Bonmarchand M, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002\u20132011 survey. AIDS. 2012;26(8):971\u201375.","journal-title":"AIDS"},{"issue":"6","key":"12621_CR35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/jac\/dkn098","volume":"61","author":"J Ghosn","year":"2008","unstructured":"Ghosn J, Chaix ML, Peytavin G, Bresson JL, Galimand J, Girard PM, et al. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir\/ritonavir alone or in combination with zidovudine\/lamivudine. J Antimicrob Chemother. 2008;61(6):1344\u201347.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"12621_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/QAI.0b013e31802c8a1c","volume":"44","author":"JB Dumond","year":"2007","unstructured":"Dumond JB, Yeh RF, Patterson KB, Corbett AH, Jung BH, Rezk NL, et al. Female genital tract pharmacokinetics of tenofovir and emtricitabine in HIV-uninfected women after oral administration of Truvada. J Acquir Immune Defic Syndr. 2007;44(3):261\u201367. https:\/\/doi.org\/10.1097\/QAI.0b013e31802c8a1c.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"12621_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/jiw077","volume":"214","author":"ML Cottrell","year":"2016","unstructured":"Cottrell ML, Yang KH, Prince HM, Sykes C, White N, Malone S, et al. A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine. J Infect Dis. 2016;214(1):55\u201364. https:\/\/doi.org\/10.1093\/infdis\/jiw077.","journal-title":"J Infect Dis"},{"issue":"10","key":"12621_CR38","first-page":"703","volume":"50","author":"LJ Else","year":"2011","unstructured":"Else LJ, Taylor S, Back DJ, Khoo SH. Pharmacokinetics of antiretroviral drugs in the female genital tract: implications for HIV prevention. Clin Pharmacokinet. 2011;50(10):703\u201314.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"12621_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/clpt.2014.84","volume":"96","author":"MR Nicol","year":"2014","unstructured":"Nicol MR, Fedoriw Y, Mathews M, Prince HM, Patterson KB, Dumond JB, et al. Efavirenz pharmacokinetics in the female genital tract: implications for HIV prevention. Clin Pharmacol Ther. 2014;96(2):200\u201309. https:\/\/doi.org\/10.1038\/clpt.2014.84.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"12621_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7196\/SAJHIVMED.975","volume":"15","author":"T Apalata","year":"2014","unstructured":"Apalata T, Carr WH, Longo-Mbenza B, Sturm WA, Moodley P. Association between symptomatic vulvovaginal candidiasis and HIV RNA levels in plasma and genital secretions among women on HAART. South Afr J HIV Med. 2014;15(2):57\u201364. https:\/\/doi.org\/10.7196\/SAJHIVMED.975.","journal-title":"South Afr J HIV Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12621-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:28:34Z","timestamp":1772018914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12621-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12621"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12621-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eligible women provided written informed consent to participate in the study and store biological specimens for future research, as approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (BE 194\/18) and in keeping with SA GCP guidelines and the declaration of Helsinki 2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"462"}}